Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![REPL Graphic](https://lunarcrush.com/gi/w:26/t:repl.png) REPL

Replimune stock plunges after FDA rejects cancer drug, leading to investor concerns and analyst downgrades. Traders are watching for potential buying opportunities amidst the volatility.

### About REPL
Replimune Group Inc. (REPL) is a biotechnology company specializing in immuno-oncology therapies.  

### Insights [#](/topic/repl/insights)
- repl Creators hit a high of XXX for the day
- repl Creators hit an all time of XXX for the day

### Engagements: XXXXXX [#](/topic/repl/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:repl/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/repl/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Month**: XXXXXXX +180,418%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-03-20  
**1-Year Low**: X on 2025-05-13  

| Social Network | X      | YouTube | News | TikTok | Reddit |
| -------------- | -      | ------- | ---- | ------ | ------ |
| Engagements    | XXXXXX | XXXXXX  | XX   | XXX    | XXX    |
  

  
  
### Mentions: XXX [#](/topic/repl/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:repl/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/repl/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XX  
**1 Month**: XXX +1,582%  
**1-Year High**: XXX on 2024-11-25  
**1-Year Low**: X on 2025-04-16  

| Social Network | X   | YouTube | News | TikTok | Reddit |
| -------------- | -   | ------- | ---- | ------ | ------ |
| Mentions       | XXX | XX      | X    | X      | XX     |
  

  
  
### Creators: XXX [#](/topic/repl/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:repl/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/repl/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning REPL in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +1,270%  
**1-Year High**: XXX on 2025-07-23  
**1-Year Low**: X on 2025-04-16  

The most influential creators that mention REPL in the last XX hours

| Creator                              | Rank | Followers | Posts | Engagements |
| -------                              | ---- | --------- | ----- | ----------- |
| [@ahfugui](/creator/twitter/ahfugui) | X    | XXX       | X     | XXX         |

[View More](/list/creators/repl/100)
  
  
### Sentiment: XX% [#](/topic/repl/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:repl/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/repl/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% +30%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2024-07-26  
**1-Year Low**: XX% on 2024-12-07  

**Most Supportive Themes**
- **Potential Rebound and Buying Opportunity:** (15%) Some traders are looking at the stock as a potential buying opportunity after the drop, with some members of trading groups seeing potential for a rebound.
- **Unusual Option Activity:** (10%) Some traders are highlighting unusual option activity, with increased call and put option volumes, indicating potential volatility and trading opportunities.
  
**Most Critical Themes**
- **FDA Rejection and Stock Collapse:** (45%)  The FDA rejected Replimune's cancer drug, causing the stock to plummet, leading to investor concern and investigations.
- **Analyst Downgrades:** (20%)  Multiple analysts downgraded Replimune (REPL) after the FDA rejection, citing the setback and impacting investor confidence.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXX      | X% |
| YouTube | XXXXX    | X%  | XXXXX   | XX% | XXXXX    | X% |
| News    | X        | X%  | XX      | X%  | X        | X% |
| TikTok  | XXX      | X%  | XXX     | X%  | X        | X% |
| Reddit  | XX       | X%  | XXX     | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
  


**Top assets mentioned**
In the posts about REPL in the last XX hours

[Circle Internet Group, Inc. (CRCL)](/topic/$crcl)
[RAI Finance (SOFI)](/topic/$sofi)
[Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Iqvia Holdings Inc (IQV)](/topic/$iqv)
[Tesla, Inc. (TSLA)](/topic/$tsla)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)
[Bristol-Myers Squibb Co (BMY)](/topic/$bmy)
[Iqvia Holdings Inc (IQV)](/topic/iqvia-holdings-inc)

**Top topics mentioned**
In the posts about REPL in the last XX hours

[investment](/topic/investment), [stocks](/topic/stocks), [stockmarket](/topic/stockmarket), [ixhl](/topic/ixhl), [nvda](/topic/nvda), [lmt](/topic/lmt), [qqq](/topic/qqq), [crcl](/topic/crcl), [dnut](/topic/dnut), [nvts](/topic/nvts), [smci](/topic/smci), [oscr](/topic/oscr), [$crcl](/topic/$crcl), [bmnr](/topic/bmnr), [huma](/topic/huma), [$sofi](/topic/$sofi), [$iova](/topic/$iova), [spy](/topic/spy), [mstr](/topic/mstr), [hood](/topic/hood), [djt](/topic/djt), [dfdv](/topic/dfdv), [rivn](/topic/rivn), [nke](/topic/nke), [javascript](/topic/javascript), [trader](/topic/trader), [$oris](/topic/$oris), [baba](/topic/baba), [rp](/topic/rp), [gme](/topic/gme), [money](/topic/money), [$srpt](/topic/$srpt), [amzn](/topic/amzn), [op](/topic/op), [lulu](/topic/lulu), [meta](/topic/meta), [cnc](/topic/cnc), [plug](/topic/plug), [amc](/topic/amc), [nio](/topic/nio), [aehr](/topic/aehr), [nasdaq](/topic/nasdaq), [replimune](/topic/replimune), [msft](/topic/msft), [stocks healthcare](/topic/stocks-healthcare), [acquisition](/topic/acquisition), [approved](/topic/approved), [$xbi](/topic/$xbi), [$dfli](/topic/$dfli), [sqns](/topic/sqns), [$mfh](/topic/$mfh), [stocks financial services](/topic/stocks-financial-services), [$tdth](/topic/$tdth), [$tnfa](/topic/$tnfa), [blk](/topic/blk), [$lcfy](/topic/$lcfy), [jpm](/topic/jpm), [$htoo](/topic/$htoo), [coins ai](/topic/coins-ai), [dawn](/topic/dawn), [$iqv](/topic/$iqv), [Sentiment](/topic/sentiment), [rklb](/topic/rklb), [pltr](/topic/pltr), [$raya](/topic/$raya), [spx](/topic/spx), [manat](/topic/manat), [$barcl](/topic/$barcl), [$tsla](/topic/$tsla), [combo](/topic/combo), [volatility](/topic/volatility), [xyz](/topic/xyz), [$gvh](/topic/$gvh), [$dnut](/topic/$dnut), [clov](/topic/clov), [lidr](/topic/lidr), [asml](/topic/asml), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$bmy](/topic/$bmy), [$nvts](/topic/$nvts), [breaking news](/topic/breaking-news), [iqvia holdings inc](/topic/iqvia-holdings-inc), [$asnd](/topic/$asnd), [$rhhby](/topic/$rhhby), [spce](/topic/spce), [$qure](/topic/$qure), [oust](/topic/oust), [hims](/topic/hims), [$capr](/topic/$capr), [$ixhl](/topic/$ixhl), [$plrz](/topic/$plrz), [$soxl](/topic/$soxl), [momentum](/topic/momentum), [hc](/topic/hc), [$shot](/topic/$shot), [le](/topic/le), [japanese yen](/topic/japanese-yen), [linkedin](/topic/linkedin), [signals](/topic/signals), [$pgen](/topic/$pgen)

### Top News [#](/topic/repl/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Replimune stock rebounds despite downgrades (REPL:NASDAQ) Seeking Alpha"  
[@SeekingAlpha](/creator/x/SeekingAlpha) on [X](/post/news/seekingalpha.com-3123311388) 2025-07-23 17:15:02 UTC 300.8K followers, 2688 engagements


"Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program (NASDAQ:REPL) Seeking Alpha"  
[@SeekingAlpha](/creator/x/SeekingAlpha) on [X](/post/news/seekingalpha.com-2201895526) 2025-07-22 23:05:03 UTC 300.8K followers, 3380 engagements


"Iovance stock gains as Replimune drug rejected (IOVA:NASDAQ) Seeking Alpha"  
[@SeekingAlpha](/creator/x/SeekingAlpha) on [X](/post/news/seekingalpha.com-278966257) 2025-07-22 18:30:02 UTC 300.8K followers, 2809 engagements


"Replimune stock down as FDA rejects cancer drug (REPL:NASDAQ) Seeking Alpha"  
[@SeekingAlpha](/creator/x/SeekingAlpha) on [X](/post/news/seekingalpha.com-1123526119) 2025-07-22 14:15:04 UTC 300.8K followers, 2185 engagements



### Top Social Posts [#](/topic/repl/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@livestoredev @schickling Doing this requires moving the state of the notebook document to the server side. Once you do this though. it unlocks new ways of working. No longer do you have to only converse with just the REPL. It's time to bring collaborators"  
[@KyleRayKelley](/creator/x/KyleRayKelley) on [X](/post/tweet/1948868852814864491) 2025-07-25 22:11:57 UTC 3783 followers, XXX engagements


"Laura Loomer now Rick Santorum.will CBER Chief #Prasad survive the pro-choice attack dogs $srpt $repl"  
[@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1948816727628021820) 2025-07-25 18:44:49 UTC 19.6K followers, 3568 engagements


"$HTOO $OPEN $MEDP $WLGS $BLMZ $GVH $NVDA $PLTR $TSLA $QBTS $QUBT $MSFT $NFLX $REPL $HOOD $MSTR $RIOT $IGEN $NVTS $PLUG $QBTS $OPEN . . "  
[@anky12300](/creator/x/anky12300) on [X](/post/tweet/1948790070045032938) 2025-07-25 16:58:54 UTC XXX followers, 1057 engagements


"Buy 10K Limit Verified Cash App Accounts $MSFT $KO $ORCL $GOOGL $NFLX $MSTR $TSLA $JPM $AAPL $OKLO $VRT $BLK $AZN $SBUX $MU $LMT $CCK $AGYS $NXPI $STLD $DHI $GRBK $RTX $NOC $KMB $BAH $CBOD $APO $META $HCA $CSX $CALX $IQV $MEDP $REPL $KRMN $BKSY $SSL"  
[@EllenTinke71051](/creator/x/EllenTinke71051) on [X](/post/tweet/1948768940106416551) 2025-07-25 15:34:56 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

REPL Graphic REPL

Replimune stock plunges after FDA rejects cancer drug, leading to investor concerns and analyst downgrades. Traders are watching for potential buying opportunities amidst the volatility.

About REPL

Replimune Group Inc. (REPL) is a biotechnology company specializing in immuno-oncology therapies.

Insights #

  • repl Creators hit a high of XXX for the day
  • repl Creators hit an all time of XXX for the day

Engagements: XXXXXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Month: XXXXXXX +180,418%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-20
1-Year Low: X on 2025-05-13

Social Network X YouTube News TikTok Reddit
Engagements XXXXXX XXXXXX XX XXX XXX

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Month: XXX +1,582%
1-Year High: XXX on 2024-11-25
1-Year Low: X on 2025-04-16

Social Network X YouTube News TikTok Reddit
Mentions XXX XX X X XX

Creators: XXX #


Creators Line Chart
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning REPL in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XX
1 Month: XXX +1,270%
1-Year High: XXX on 2025-07-23
1-Year Low: X on 2025-04-16

The most influential creators that mention REPL in the last XX hours

Creator Rank Followers Posts Engagements
@ahfugui X XXX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
6 Months: XX% +30%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-26
1-Year Low: XX% on 2024-12-07

Most Supportive Themes

  • Potential Rebound and Buying Opportunity: (15%) Some traders are looking at the stock as a potential buying opportunity after the drop, with some members of trading groups seeing potential for a rebound.
  • Unusual Option Activity: (10%) Some traders are highlighting unusual option activity, with increased call and put option volumes, indicating potential volatility and trading opportunities.

Most Critical Themes

  • FDA Rejection and Stock Collapse: (45%) The FDA rejected Replimune's cancer drug, causing the stock to plummet, leading to investor concern and investigations.
  • Analyst Downgrades: (20%) Multiple analysts downgraded Replimune (REPL) after the FDA rejection, citing the setback and impacting investor confidence.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXX XX% XXXXXX XX% XXX X%
YouTube XXXXX X% XXXXX XX% XXXXX X%
News X X% XX X% X X%
TikTok XXX X% XXX X% X X%
Reddit XX X% XXX X% X X%
Total XXXXXX XX% XXXXXX XX% XXXXX X%

Top assets mentioned In the posts about REPL in the last XX hours

Circle Internet Group, Inc. (CRCL) RAI Finance (SOFI) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Sarepta Therapeutics, Inc. (SRPT) Bitcoin Incognito (XBI) Iqvia Holdings Inc (IQV) Tesla, Inc. (TSLA) Sarepta Therapeutics, Inc. (SRPT) Bristol-Myers Squibb Co (BMY) Iqvia Holdings Inc (IQV)

Top topics mentioned In the posts about REPL in the last XX hours

investment, stocks, stockmarket, ixhl, nvda, lmt, qqq, crcl, dnut, nvts, smci, oscr, $crcl, bmnr, huma, $sofi, $iova, spy, mstr, hood, djt, dfdv, rivn, nke, javascript, trader, $oris, baba, rp, gme, money, $srpt, amzn, op, lulu, meta, cnc, plug, amc, nio, aehr, nasdaq, replimune, msft, stocks healthcare, acquisition, approved, $xbi, $dfli, sqns, $mfh, stocks financial services, $tdth, $tnfa, blk, $lcfy, jpm, $htoo, coins ai, dawn, $iqv, Sentiment, rklb, pltr, $raya, spx, manat, $barcl, $tsla, combo, volatility, xyz, $gvh, $dnut, clov, lidr, asml, sarepta therapeutics inc, $bmy, $nvts, breaking news, iqvia holdings inc, $asnd, $rhhby, spce, $qure, oust, hims, $capr, $ixhl, $plrz, $soxl, momentum, hc, $shot, le, japanese yen, linkedin, signals, $pgen

Top News #


Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"Replimune stock rebounds despite downgrades (REPL:NASDAQ) Seeking Alpha"
@SeekingAlpha on X 2025-07-23 17:15:02 UTC 300.8K followers, 2688 engagements

"Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program (NASDAQ:REPL) Seeking Alpha"
@SeekingAlpha on X 2025-07-22 23:05:03 UTC 300.8K followers, 3380 engagements

"Iovance stock gains as Replimune drug rejected (IOVA:NASDAQ) Seeking Alpha"
@SeekingAlpha on X 2025-07-22 18:30:02 UTC 300.8K followers, 2809 engagements

"Replimune stock down as FDA rejects cancer drug (REPL:NASDAQ) Seeking Alpha"
@SeekingAlpha on X 2025-07-22 14:15:04 UTC 300.8K followers, 2185 engagements

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"@livestoredev @schickling Doing this requires moving the state of the notebook document to the server side. Once you do this though. it unlocks new ways of working. No longer do you have to only converse with just the REPL. It's time to bring collaborators"
@KyleRayKelley on X 2025-07-25 22:11:57 UTC 3783 followers, XXX engagements

"Laura Loomer now Rick Santorum.will CBER Chief #Prasad survive the pro-choice attack dogs $srpt $repl"
@RNAiAnalyst on X 2025-07-25 18:44:49 UTC 19.6K followers, 3568 engagements

"$HTOO $OPEN $MEDP $WLGS $BLMZ $GVH $NVDA $PLTR $TSLA $QBTS $QUBT $MSFT $NFLX $REPL $HOOD $MSTR $RIOT $IGEN $NVTS $PLUG $QBTS $OPEN . . "
@anky12300 on X 2025-07-25 16:58:54 UTC XXX followers, 1057 engagements

"Buy 10K Limit Verified Cash App Accounts $MSFT $KO $ORCL $GOOGL $NFLX $MSTR $TSLA $JPM $AAPL $OKLO $VRT $BLK $AZN $SBUX $MU $LMT $CCK $AGYS $NXPI $STLD $DHI $GRBK $RTX $NOC $KMB $BAH $CBOD $APO $META $HCA $CSX $CALX $IQV $MEDP $REPL $KRMN $BKSY $SSL"
@EllenTinke71051 on X 2025-07-25 15:34:56 UTC XXX followers, XXX engagements

REPL
/topic/repl